SNX TD SYNNEX CORP Insider Trading

Director Richard T Hume sold 5,000 SNX shares for $1.2M via scheduled 10b5-1 plan on 2026-07-06

Richard T Hume (Director) executed 10 separate sales totaling 5,000 shares for $1,214,858.14 on 2026-07-06 at prices ranging from $237.93 to $248.28, blended average $242.97. This transaction is part of a pre-arranged 10b5-1 trading plan adopted 2026-02-02, meaning it was scheduled rather than discretionary. Post-transaction holdings stand at 18,537 shares, a -21.2% reduction from pre-transaction holdings of 23,537 shares. SNX trades at $235.67 currently, -20.5% from the 52-week high of $296.47 and down 12.3% over the prior 30 days. Hume's prior five same-ticker sales at SNX (all on 2026-06-02) each showed negative 30-day outcomes ranging from -10.3% to -14.1%, indicating these recent months have been unfavorable exit windows; however, this latest sale is schedule-driven, not discretionary timing.

Dennis Polk (Chair, TD SYNNEX) sells 10,000 shares for $2,684,780 across 2 transactions on 2026-06-30

Dennis Polk, Chair of TD SYNNEX, executed 2 separate sales totaling 10,000 shares for $2,684,780.00 at a blended average price of $268.48. His post-transaction holdings of 22,439 shares represent a -30.8% reduction from pre-transaction holdings of 32,439 shares. The stock is currently trading at $261.35, which is -11.8% from the 52-week high of $296.47 and -3.4% over the past 30 days, though it has posted a +39.8% gain over 90 days. Polk's prior trades at this ticker show mixed timing outcomes: three January 2026 sales posted 90-day gains of +32.9%, +33.4%, and +33.5%, while two October 2025 sales posted 90-day declines of -3.0% and -3.8%, with 2 of 5 prior sells at SNX being well-timed at the 90-day mark. Derivative holdings of 4,566 shares (1,661 stock options and 2,905 employee stock options) remain outstanding post-transaction.

Dennis Polk (Chair) sells 15,000 SNX shares for $3,980,775.68; retains 22,439 shares plus 12,581 options

Dennis Polk, Chair of Hyve Solutions, executed 3 separate sales totaling 15,000 shares for $3,980,775.68 at an average price of $265.39 on 2026-06-29, reducing his non-derivative holdings by 40.1% to 22,439 shares while retaining 12,581 employee stock options. The current price of $267.34 sits 9.8% below the 52-week high of $296.47, and the stock has appreciated 2.3% over the last 30 days and 43.5% over the last 90 days. At the same ticker (SNX), Polk's prior 5 trades show mixed timing outcomes: his 2 most recent sales in January 2026 were followed by gains of +13.2% to +13.6% (30-day) and +32.9% to +33.5% (90-day), while his October 2025 sales showed modest declines. With TD SYNNEX trading at a P/E of 21.77 on $17.2B in annual revenue (up 6.9% year-over-year) and $326.9M in net income, this sale represents a partial reduction of a significant executive position in a mid-cap technology distributor during a period of sustained stock strength.

Director Richard T Hume sells 5,000 shares ($1.4M) at SNX under pre-arranged 10b5-1 plan

Richard T Hume, a director, executed 11 separate sales totaling 5,000 shares for $1,401,893.63 on 2026-06-02 under a 10b5-1 trading plan adopted on 2026-02-02, reducing his stake from 28,537 shares to 23,537 shares. This is a scheduled, non-discretionary transaction, so the sale timing reflects plan mechanics rather than director judgment. His prior trades at SNX show 30-day returns ranging from +20.4% to +22.6%, suggesting his past exit points at this ticker have historically been followed by continued stock appreciation. The current stock price of $279.25 sits -2.4% from the 52-week high of $286.25, while the 30-day and 90-day changes are +22.6% and +76.7% respectively, indicating the stock has rallied substantially in recent periods.

Director Richard T Hume executes 6 scheduled sales totaling 5,000 shares at SNX via 10b5-1 plan; retains 28,537 shares.

Richard T Hume sold 5,000 shares across 6 separate transactions on 2026-05-18, with prices ranging from $227.93 to $232.07 and a blended average of $229.54, for a total of $1,147,691.83. This sale reduces his holdings from 33,537 shares to 28,537 shares (-14.9% net change). The transaction is part of a pre-arranged 10b5-1 trading plan adopted 2026-02-02, meaning the sales were scheduled and not discretionary. At current price of $227.88, the stock trades -6.0% from its 52-week high of $242.49 and +6.3% over the past 30 days. Hume's prior sales at SNX (5 trades on 2026-05-05) showed modest negative 30-day and 90-day returns, though his cross-ticker track record showed average 90-day returns of +23.6% following prior sales, indicating mixed timing signals across his broader transaction history.

Director Richard T. Hume sells 5,000 SNX shares for $1.17M; repeat seller shows conflicting short- vs. long-term timing on prior trades.

Richard T. Hume, a director at TD SYNNEX, sold 5,000 shares on a single trading day for approximately $1.17 million, representing his tenth open-market sale at this company over the past three years. The stock is trading below its 52-week high but has rallied significantly over recent months on improving fundamentals—the company is profitable with growing revenue. Hume's five prior sales at SNX present a mixed timing picture: all five were well-timed at the 30-day horizon, meaning the stock did not rise further in the immediate aftermath, but all five proved poorly timed over the longer 90-day window as shares recovered and advanced substantially. This conflicting pattern—early timing that looked correct versus delayed outcomes that questioned the exit—repeats in his current sale. As a director with modest holdings, Hume continues a consistent pattern of open-market sales rather than purchases, adding to his track record of exits across his entire portfolio over the three-year filing window.

Director Saintil Merline sells majority stake worth ~$1M, trimming position as stock reaches near 52-week highs amid strong recent momentum.

Director Saintil Merline liquidated more than half of her holdings in a single transaction, offloading roughly one million dollars worth of TD SYNNEX stock. The timing is noteworthy: the stock is trading essentially at its 52-week high after a sharp run-up, having gained significantly over both the past month and quarter. This is classic opportunistic selling—a director taking advantage of a peak to diversify, rather than a panic exit during weakness. TD SYNNEX remains operationally healthy with profitable operations and strong revenue growth, so the sale doesn't signal fundamental distress. However, the decision to reduce exposure this substantially right at the peak, combined with the stock's already stretched valuation, suggests Merline saw a window to lock in gains and decided to take it.

Murphy Miriam Anne (President, Europe) sold 3.0K shares of SNX at $200.14; holdings reduced 21.8% to 10.8K.

Murphy Miriam Anne, President of Europe at TD SYNNEX, sold 3,025 shares at $200.14 on 2026-04-09, reducing her post-transaction holdings to 10.8K shares from 13.8K shares—a 21.8% reduction in her position. The sale occurred near the 52-week high of $200.22 (-0.4% from peak), and the stock has appreciated sharply recently: 30-day change of +28.2% and 90-day change of +32.6%. This is a regional executive (not C-suite) liquidating a material but not dominant portion of her equity stake in a mid-large-cap distributor trading at a P/E of 16.24 with stable fundamentals (annual revenue growth of 6.9%, $326.9M net income on $17.2B revenue). The sale's proximity to recent highs and the substantial percentage reduction merit investor attention to distinguish between portfolio-level rebalancing and any change in insider conviction regarding SNX valuation or business trajectory.

TD SYNNEX CFO Gregory sells 3,225 shares at $189.46 for $611.0K; retains 14,035 shares post-sale

Jordan David Gregory, CFO of TD SYNNEX, sold 3,225 shares at $189.46 on 2026-04-06, reducing his holdings from 17,260 shares to 14,035 shares (net -18.7%). The sale occurred near the 52-week high of $193.11, with the stock up 23.5% over 30 days and 26.9% over 90 days. The company shows stable fundamentals with $17.2B in latest quarterly revenue, $326.9M net income, and a 15.73 P/E ratio. Gregory retained a substantial stake post-sale, signaling ongoing alignment despite the reduction in holdings.

SNX CEO Zammit sells 13,900 shares at $171.57; stock near 52-week high at $172.18, up 14.4% in 30 days

Zammit Patrick, CEO of TD SYNNEX CORP, sold 13,900 shares (reducing holdings from 184.8K to 170.9K shares, a -7.5% reduction) at $171.57 on 2026-02-06, generating $2.4M in proceeds at a price near the stock's 52-week high of $172.18. The stock has appreciated 14.4% over the past 30 days and 15.2% over 90 days, positioning this sale at elevated valuation levels. Zammit's prior open-market sell activity shows a 100% well-timed rate at the 90-day mark, with his single prior transaction at SNX (sold 2025-01-30) delivering -22.5% over 90 days; however, the current transaction's future timing outcome cannot yet be assessed. The company's fundamentals appear sound with $15.7B in latest-quarter revenue, $226.8M net income, +6.9% annual revenue growth, and a P/E of 15.24, providing no obvious distress signals from the earnings side.